血管加压-话题@MedSci - 梅斯（MedSci）

#血管加压#

18篇内容 | 679人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1812289, encodeId=9b1018122899c, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=急诊休克血管加压药物如何选？牢记这张图！, objectType=article, longId=294409, objectId=8ec729440949, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ec729440949, replyNumber=0, likeNumber=98, createdTime=2022-11-26, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ec729440949, moduleTitle=急诊休克血管加压药物如何选？牢记这张图！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8ec729440949)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812288, encodeId=4740181228856, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=JAMA：血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复, objectType=article, longId=218146, objectId=2b23218146ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b23218146ee, replyNumber=0, likeNumber=0, createdTime=2021-12-25, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b23218146ee, moduleTitle=JAMA：血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2b23218146ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812287, encodeId=4fb7181228e65, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=Crit Care：与通过外周静脉输注血管加压药相关的不良事件, objectType=article, longId=210090, objectId=e04521009013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e04521009013, replyNumber=0, likeNumber=97, createdTime=2022-03-13, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e04521009013, moduleTitle=Crit Care：与通过外周静脉输注血管加压药相关的不良事件, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e04521009013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812286, encodeId=db561812286e8, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=JAMA：血管加压素联合儿茶酚胺与单独应用儿茶酚胺治疗分配性休克患者房颤发生率的比较：系统回顾及META-分析, objectType=article, longId=190678, objectId=abfb1906e8e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abfb1906e8e1, replyNumber=0, likeNumber=70, createdTime=2020-12-08, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abfb1906e8e1, moduleTitle=JAMA：血管加压素联合儿茶酚胺与单独应用儿茶酚胺治疗分配性休克患者房颤发生率的比较：系统回顾及META-分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=abfb1906e8e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812285, encodeId=e22d1812285bd, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=2019 CCCS临床实践指南：血管加压素和加压素类似物在分布性休克危重患者中的应用, objectType=article, longId=184709, objectId=4ab8184e0906, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ab8184e0906, replyNumber=0, likeNumber=83, createdTime=2020-04-12, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ab8184e0906, moduleTitle=2019 CCCS临床实践指南：血管加压素和加压素类似物在分布性休克危重患者中的应用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ab8184e0906)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812284, encodeId=53cc181228417, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?, objectType=article, longId=174655, objectId=52951e465521, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52951e465521, replyNumber=0, likeNumber=101, createdTime=2020-03-23, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52951e465521, moduleTitle=脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=52951e465521)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812282, encodeId=924b181228230, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=JACC：血管加压药到底该选哪个？去甲肾上腺素vs肾上腺素, objectType=article, longId=142624, objectId=382b1426241c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=382b1426241c, replyNumber=0, likeNumber=80, createdTime=2018-11-09, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=382b1426241c, moduleTitle=JACC：血管加压药到底该选哪个？去甲肾上腺素vs肾上腺素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=382b1426241c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812283, encodeId=f34f181228385, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=Crit Care Med：血管加压剂的使用增加了创伤性失血性休克患者的死亡风险, objectType=article, longId=148650, objectId=93c5148650f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93c5148650f6, replyNumber=0, likeNumber=110, createdTime=2019-07-22, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93c5148650f6, moduleTitle=Crit Care Med：血管加压剂的使用增加了创伤性失血性休克患者的死亡风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93c5148650f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812279, encodeId=467818122e93c, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=Intens Care Med：血管加压素治疗脓毒症和血管扩张性休克时不同血压目标值的比较分析！, objectType=article, longId=124628, objectId=ef3e124628bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef3e124628bd, replyNumber=0, likeNumber=88, createdTime=2018-07-13, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef3e124628bd, moduleTitle=Intens Care Med：血管加压素治疗脓毒症和血管扩张性休克时不同血压目标值的比较分析！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ef3e124628bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812281, encodeId=efb61812281a3, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=Intensive Care Med：血管加压素治疗休克——高vs低血压目标对结局有何影响？, objectType=article, longId=130487, objectId=873213048ecb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873213048ecb, replyNumber=0, likeNumber=67, createdTime=2018-04-01, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873213048ecb, moduleTitle=Intensive Care Med：血管加压素治疗休克——高vs低血压目标对结局有何影响？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=873213048ecb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812276, encodeId=5d9118122e6e1, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=N Engl J Med：治疗顽固性休克：血管加压素和去甲肾上腺素哪家强, objectType=article, longId=103793, objectId=4399103e93a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4399103e93a7, replyNumber=0, likeNumber=83, createdTime=2017-11-24, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4399103e93a7, moduleTitle=N Engl J Med：治疗顽固性休克：血管加压素和去甲肾上腺素哪家强, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4399103e93a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812280, encodeId=d4dc18122809e, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据, objectType=article, longId=124941, objectId=5a5b12494193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a5b12494193, replyNumber=0, likeNumber=75, createdTime=2018-01-20, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a5b12494193, moduleTitle=EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5a5b12494193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812277, encodeId=b21e18122e74e, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=J Crit Care：血管加压素联合氢化可的松对休克血流动力学紊乱的影响, objectType=article, longId=104324, objectId=f2a8104324d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2a8104324d8, replyNumber=0, likeNumber=102, createdTime=2017-12-21, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2a8104324d8, moduleTitle=J Crit Care：血管加压素联合氢化可的松对休克血流动力学紊乱的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f2a8104324d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812278, encodeId=983c18122e8d5, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=J Crit Care：血管加压素联合氢化可的松对休克患者血流动力学紊乱的影响, objectType=article, longId=106699, objectId=96841066995f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96841066995f, replyNumber=0, likeNumber=91, createdTime=2018-01-26, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96841066995f, moduleTitle=J Crit Care：血管加压素联合氢化可的松对休克患者血流动力学紊乱的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=96841066995f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812275, encodeId=8ee218122e561, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=Ann Surg：术中使用血管加压剂不会增加自由瓣膜的损害和失败风险！, objectType=article, longId=98650, objectId=936c98650d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=936c98650d1, replyNumber=0, likeNumber=89, createdTime=2017-06-03, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=936c98650d1, moduleTitle=Ann Surg：术中使用血管加压剂不会增加自由瓣膜的损害和失败风险！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=936c98650d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812274, encodeId=cd9018122e4b0, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=AHA 2014：血管加压素治疗心搏骤停和创伤可行？, objectType=article, longId=42798, objectId=909b42e98e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=909b42e98e9, replyNumber=0, likeNumber=80, createdTime=2015-05-24, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=909b42e98e9, moduleTitle=AHA 2014：血管加压素治疗心搏骤停和创伤可行？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=909b42e98e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812273, encodeId=259b18122e33c, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=EJA：体外循环手术中用脑电双频指数确定七氟醚含量可以减少血浆七氟醚密度以及血管加压药的使用：一项前瞻性、对照、序贯双臂研究, objectType=article, longId=39195, objectId=72f839195e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72f839195e6, replyNumber=0, likeNumber=76, createdTime=2014-11-03, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72f839195e6, moduleTitle=EJA：体外循环手术中用脑电双频指数确定七氟醚含量可以减少血浆七氟醚密度以及血管加压药的使用：一项前瞻性、对照、序贯双臂研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=72f839195e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1812272, encodeId=386618122e213, content=<a href='/topic/show?id=0368895e22e' target=_blank style='color:#2F92EE;'>#血管加压#</a>, objectTitle=日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市, objectType=article, longId=4134, objectId=c16b4134b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16b4134b8, replyNumber=0, likeNumber=73, createdTime=2012-07-17, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16b4134b8, moduleTitle=日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c16b4134b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血管加压

2020-05-29

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

急诊休克血管加压药物如何选？牢记这张图！

2022-11-26

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

JAMA：血管加压素和甲强龙能显著改善院内心脏骤停患者自发循环恢复

2021-12-25

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

Crit Care：与通过外周静脉输注血管加压药相关的不良事件

2022-03-13

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

JAMA：血管加压素联合儿茶酚胺与单独应用儿茶酚胺治疗分配性休克患者房颤发生率的比较：系统回顾及META-分析

2020-12-08

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

2019 CCCS临床实践指南：血管加压素和加压素类似物在分布性休克危重患者中的应用

2020-04-12

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

脓毒症休克中的血管加压素: 我们所知道的，下一步该去哪里?

2020-03-23

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

JACC：血管加压药到底该选哪个？去甲肾上腺素vs肾上腺素

2018-11-09

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

Crit Care Med：血管加压剂的使用增加了创伤性失血性休克患者的死亡风险

2019-07-22

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

Intens Care Med：血管加压素治疗脓毒症和血管扩张性休克时不同血压目标值的比较分析！

2018-07-13

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

Intensive Care Med：血管加压素治疗休克——高vs低血压目标对结局有何影响？

2018-04-01

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

N Engl J Med：治疗顽固性休克：血管加压素和去甲肾上腺素哪家强

2017-11-24

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

EUR J PHARMACOL：二甲双胍阻断由刺激α1-和α2-肾上腺素能受体介导的血管加压素反应的药理学证据

2018-01-20

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

J Crit Care：血管加压素联合氢化可的松对休克血流动力学紊乱的影响

2017-12-21

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

J Crit Care：血管加压素联合氢化可的松对休克患者血流动力学紊乱的影响

2018-01-26

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

Ann Surg：术中使用血管加压剂不会增加自由瓣膜的损害和失败风险！

2017-06-03

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

AHA 2014：血管加压素治疗心搏骤停和创伤可行？

2015-05-24

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

EJA：体外循环手术中用脑电双频指数确定七氟醚含量可以减少血浆七氟醚密度以及血管加压药的使用：一项前瞻性、对照、序贯双臂研究

2014-11-03

仁心济世 (审核中...)

前往app查看评论内容

#血管加压#

日本大冢公司血管加压素受体拮抗剂托伐普坦（苏麦卡）在中国上市

2012-07-17

科室
- - 订阅+
  - 更多科室
工具
服务